825 patients.Eight psychiatrists.
Leros, March 1993. One shower for every 36 people.
No campaigner reported this. Inspectors from the Council of Europe counted it.
Twelve years earlier, a Greek presidential decree had created 225 posts of Patient Guard at the same institution — and five posts of director-psychiatrist. This page is not anti-psychiatry. It is a file on specific practices that were documented, and on the people who stopped them — most of whom were psychiatrists. Forty-three claims were checked against their primary sources; eight did not hold, and are published in Part X with the reason for each failure.
FOR LEUCOTOMY
TO THE LANCET
AVERSION THERAPY
LEROS
UNITED KINGDOM
How to read this page
The problem with the material circulating about psychiatry is not that all of it is false. It is that it mixes documented findings from official inspections with claims that do not hold, and so discredits both. Every finding here carries its level of proof — the same system as psychdrugs.org:
A judgment, an inquest conclusion or an Act. Decided by a competent body.
An official inspection report, government agency finding or international body.
Published research broadly accepted in the literature.
Live disagreement, scientific or legal. Both sides are given.
A claim that circulates, but for which no primary source was found. Cited with the gap declared.
Ten sections, each documented on its own
Every section stands alone, with its own sources. Start with whichever concerns you.
What this page does not say
Because this material is often used to support conclusions that do not follow from it:
- It does not say psychiatry is a fraud. It says specific practices were documented as harmful — and that most of them were stopped by psychiatrists.
- It does not tell you to stop treatment, refuse care, or distrust your doctor. Stopping psychiatric medication abruptly can be dangerous.
- It does not claim that psychiatry today is psychiatry in 1949 or 1993. Where a practice has been banned or reformed, that is written in the same paragraph as the finding.
- It does not say involuntary detention is banned internationally. One UN body argues that; another UN body and the European Court of Human Rights expressly disagree.
- It uses no documentation from campaigning organisations, whatever their position. No proof here comes from a body that decided its conclusion in advance.
The difference between an evidence file and an indictment is that the file also publishes what does not hold. Eight of this page's forty-three claims did not survive checking, and are published as such.
What you can do with this
- Check it. Every claim carries a DOI, a PMID, a case number or an official report number. We are not asking you to believe us.
- If this concerns you or someone close to you in hospital, the rights and time limits in the relevant statute are specific. Greece's two Strasbourg rulings were precisely about failure to observe limits the law already sets.
- Do not repeat numbers without a source, whatever they show. The eight that were rejected circulate widely and sound serious.
- No treatment decision is made from a website. Not from this one either. Talk to your treating doctor.
- If you find an error, write to me. Corrections are recorded, not silently deleted.
The sister fileFor the drugs themselves — guilty pleas, FDA and MHRA warnings, and national prescription data — there is a separate file built to the same sourcing rules.
psychdrugs.org →All sources
The full list of 66 sources. Each section repeats only the ones it cites.
- [1]European Committee for the Prevention of Torture (CPT), "Report to the Government of Greece on the visit to Greece carried out from 14 to 26 March 1993", CPT/Inf (94) 20 — §§195–196, 202, 207, 226–233, 254, 278–280
- [2]Council Regulation (EEC) No 815/84 of 26 March 1984 on exceptional financial support in favour of Greece in the social field, OJ L 88, 31.3.1984, pp. 1–3 (CELEX 31984R0815)
- [3]European Parliament, "Resolution on the treatment of the mental defectives on the Greek island of Leros", B3-0560/93, 22.04.1993, OJ C 150, 31.5.1993, pp. 269–270
- [4]Greek Ministry of Health, "PSYCHARGOS C (2011–2020) — Revision plan for the PSYCHARGOS Programme", November 2011
- [5]State Therapeutic Hospital – General Hospital – Health Centre of Leros, official site; 2nd Health Region of Piraeus and the Aegean
- [6]2024 inpatient census, journal Psychiatriki — four of its six authors are connected to the institution
- [7]Independent Inquiry into the death of David Bennett, HSG(94)27, Norfolk, Suffolk and Cambridgeshire Strategic Health Authority, chaired by Sir John Blofeld, December 2003
- [8]NICE guideline NG10, "Violence and aggression: short-term management", 2015
- [9]Regulation 28 Report to Prevent Future Deaths, South London Coroner's Court, death of Olaseni Lewis, Senior Coroner Selena Lynch, 28.06.2017, ref 2017-0205
- [10]Mental Health Units (Use of Force) Act 2018, 2018 c. 27 (United Kingdom)
- [11]US General Accounting Office, "Mental Health: Improper Restraint or Seclusion Use Places People at Risk", GAO/HEHS-99-176, September 1999
- [12]42 CFR § 482.13(g) — requirement to report restraint-related deaths
- [13]UN Committee on the Rights of Persons with Disabilities, General Comment No. 1 (2014), CRPD/C/GC/1, §§40, 42
- [14]CRPD Committee, "Guidelines on article 14 of the Convention", 14th session, 2015
- [15]UN Human Rights Committee, General Comment No. 35 (2014)
- [16]ECtHR, Rooman v Belgium, Grand Chamber
- [17]ECtHR, Venios v Greece, no. 33055/08, First Section, 05.07.2011
- [18]ECtHR, Karamanof v Greece, no. 46372/09, First Section, 26.07.2011
- [19]Stylianidis S, Peppou LE, Drakonakis N et al. "Mental health care in Athens: Are compulsory admissions in Greece a one-way road?" Int J Law Psychiatry 2017;52:28-34, DOI 10.1016/j.ijlp.2017.04.001, PMID 28431745
- [20]Sheridan Rains L, Zenina T, Casanova Dias M et al. "Variations in patterns of involuntary hospitalisation and in legal frameworks", Lancet Psychiatry 2019;6(5):403-417
- [21]Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L. "Financial ties between DSM-IV panel members and the pharmaceutical industry", Psychother Psychosom 2006;75(3):154-160, DOI 10.1159/000091772, PMID 16636630
- [22]Cosgrove L, Krimsky S. "A comparison of DSM-IV and DSM-5 panel members' financial associations with industry", PLoS Med 2012;9(3):e1001190, DOI 10.1371/journal.pmed.1001190
- [23]Davis LC, Diianni AT, Drumheller SR et al. "Undisclosed financial conflicts of interest in DSM-5-TR", BMJ 2024;384:e076902, DOI 10.1136/bmj-2023-076902
- [24]Regier DA, Narrow WE, Clarke DE et al. "DSM-5 field trials in the United States and Canada, Part II", Am J Psychiatry 2013;170(1):59-70 — the table of kappa values was not obtained
- [25]Kraemer HC, Kupfer DJ, Clarke DE, Narrow WE, Regier DA. «DSM-5: How Reliable Is Reliable Enough?» Am J Psychiatry 2012;169(1):13-15, DOI 10.1176/appi.ajp.2011.11010050 — published a year before the results
- [26]American Psychiatric Association, "Highlights of Changes from DSM-IV-TR to DSM-5", "Bereavement Exclusion" section
- [27]Frances AJ, Widiger T. "Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future", Annu Rev Clin Psychol 2012;8:109-130, PMID 22035240
- [28]Frances AJ, Nardo JM. "ICD-11 should not repeat the mistakes made by DSM-5", Br J Psychiatry 2013;203(1):1-2
- [29]World Health Assembly, Resolution WHA72.15, "Eleventh revision of the International Classification of Diseases", 28.05.2019
- [30]Greek ministerial decision establishing "ICD-10-GrM (Greek Modification)", 2018
- [31]UCSF Industry Documents Library, POGO Investigation on Ghostwriting Collection, case "Paxil, C.P.Ct.PA" — litigation exhibits (STI proposal 03.04.1998; manuscript draft with title page)
- [32]Keller MB et al. "Efficacy of paroxetine in the treatment of adolescent major depression", J Am Acad Child Adolesc Psychiatry 2001;40(7):762-772
- [33]"Expression of Concern: Efficacy of Paroxetine in the Treatment of Adolescent Major Depression", J Am Acad Child Adolesc Psychiatry 2026;65(6):852, DOI 10.1016/j.jaac.2025.09.032 — the text of the notice was not obtained
- [34]Healy D, Cattell D. "Interface between authorship, industry and science in the domain of therapeutics", Br J Psychiatry 2003;183:22-27, DOI 10.1192/bjp.183.1.22 — D. Healy has acted as a paid expert witness for plaintiffs
- [35]Nobel Prize Outreach, Nobel Prize in Physiology or Medicine 1949; Statutes of the Nobel Foundation, § 10
- [36]Caruso JP, Sheehan JP, Neurosurgical Focus 2017 — "more than 3,000" lobotomies
- [37]El-Hai J. The Lobotomist, 2005 — secondary, a trade biography; source of the figure 3,439, never independently audited
- [38]Sakel M, Wiener Medizinische Wochenschrift, 1934 (announced to the Vienna Medical Society, 1933)
- [39]Bourne H. "The insulin myth", Lancet 1953;265(6793):964-968
- [40]Ackner B, Harris A, Oldham AJ — randomised comparison, 1957
- [41]MacCulloch MJ, Feldman MP. "Aversion therapy in management of 43 homosexuals", Br Med J 1967;2(5552):594-597, DOI 10.1136/bmj.2.5552.594, PMID 6025594
- [42]Sexual Offences Act 1967 (England and Wales)
- [43]Spitzer RL, letter to the editor, Arch Sex Behav 2012;41(4):757 — a retraction request the editor declined; the 2003 paper carries no retraction notice
- [44]UN Independent Expert on protection against violence and discrimination based on sexual orientation and gender identity, A/HRC/44/53, 2020
- [45]Bonnie RJ. "Political Abuse of Psychiatry in the Soviet Union and in China", J Am Acad Psychiatry Law 2002;30(1):136-144
- [46]Bloch S. "Athens and beyond: Soviet psychiatric abuse and the World Psychiatric Association", Psychiatric Bulletin 1990;14(3):129-133, DOI 10.1192/pb.14.3.129
- [47]Helsinki Watch (Human Rights Watch), "The Legacy of Psychiatric Abuse in the USSR", May 1990
- [48]Mental Health Act 1983 (England and Wales), ss. 58A and 62
- [49]Mental Health (Care and Treatment) (Scotland) Act 2003
- [50]Kaliora SC, Braga RJ, Petrides G et al. "The practice of electroconvulsive therapy in Greece", J ECT 2013;29(3):219-224, DOI 10.1097/YCT.0b013e31827e0d49, PMID 23296395
- [51]HHS Office of Inspector General, "Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents", OEI-07-08-00150, May 2011
- [52]Banerjee S. "The use of antipsychotic medication for people with dementia: Time for action", report to the UK Department of Health, 2009 — retrieved from a mirror; re-sourcing from the UK National Archives is outstanding
- [53]US Government Accountability Office, "Residential Treatment Programs: Concerns Regarding Abuse and Death in Certain Programs for Troubled Youth", GAO-08-146T, 10.10.2007
- [54]Rosenhan DL. "On being sane in insane places", Science 1973;179(4070):250-258
- [55]Cahalan S. The Great Pretender, 2019 — secondary, a trade non-fiction work
- [56]Scull A, History of Psychiatry — analysis of Cahalan's findings in the peer-reviewed literature
- [57]Spitzer RL, methodological critique of the Rosenhan experiment, 1975
- [58]van Voren R. "Political abuse of psychiatry — an historical overview", Schizophr Bull 2010;36(1):33-35, DOI 10.1093/schbul/sbp119
- [59]Giannakopoulos G, Anagnostopoulos DC, BJPsych Bull 2016 — the figure "4,000" is not independent of source [60]
- [60]Goutidis C., Georgiou A., "State Therapeutic Hospital of Leros", historical presentation, Leros, August 2009, republished by a Dodecanese social co-operative — cites Royal Decree 119/1965 (Gazette A 30), Presidential Decree 620/1981 (Gazette A 157), Gazette B 182/1987 and the admissions register; both authors worked at the institution itself, and the gazette issues were not opened at the National Printing House
- [61]"Psychiatrists Approve Change on Homosexuals", The New York Times, 9 April 1974 — contemporaneous journalism about the APA announcement; the ballot record was not obtained
- [62]"8 Psychiatrists Are Seeking New Vote on Homosexuality as Mental Illness", The New York Times, 26 May 1974 — gives the total of 17,910 eligible voters
- [63]Greek Law 2071/1992 "Modernisation and Organisation of the Health System", Government Gazette 123/A/15.07.1992, Articles 95–99 — text cross-checked across three independent Greek legal databases; no instrument specific to electroconvulsive therapy was found
- [64]Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. "The Cognitive Effects of Electroconvulsive Therapy in Community Settings", Neuropsychopharmacology 2007;32:244-254, DOI 10.1038/sj.npp.1301180 — the largest prospective study of cognitive effects; led by a leading advocate of the method
- [65]Read J, Kirsch I, McGrath L. "Electroconvulsive Therapy for Depression: A Review of the Quality of ECT versus Sham ECT Trials and Meta-Analyses", Ethical Human Psychology and Psychiatry 2019;21(2):64-103
- [66]Anderson IM. "Electroconvulsive therapy (ECT) versus sham ECT for depression: do study limitations invalidate the evidence (and mean we should stop using ECT)?", BJPsych Advances 2021;27(5):285-291 — the defence of the method; concedes there is next to no evidence of efficacy after the end of acute treatment